DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

AksharChem India Limited — Board Meeting Intimation

NSE 1 hr ago·9 Oct 2026, 11:18 am

AksharChem India

AksharChem India Limited has announced that its board will meet on October 19, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026.

This update is a routine corporate procedure that provides investors with an early look at the company's financial health. For shareholders, the results will offer insight into the company's operational performance and profitability during this interim period.

Investors should monitor the release of these results to gauge the company's growth trajectory and compare its performance against market expectations and its own historical data.